Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
04 2019
Historique:
received: 10 10 2018
revised: 16 11 2018
accepted: 23 11 2018
pubmed: 12 12 2018
medline: 20 11 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Five percent of urothelial carcinoma occurs in the upper urinary tract (UUT), a challenging location to biopsy. We aim to evaluate concordance between biopsy, cytology, and resection specimens in a large upper tract urothelial carcinoma (UTUC) cohort. One hundred seventeen UTUC resections with UUT biopsy and/or cytology specimens from 2000 to 2016 were retrieved; pathologic material was re-reviewed, evaluated for concordance, and correlated with clinical information. Fourteen percent of preoperative biopsies, including 8 from the renal pelvis and 6 from the ureter, lacked neoplastic diagnoses. Seventy-seven percent of diagnostic biopsies included subepithelial tissue; 11% demonstrated reclassification of grade and 30% demonstrated reclassification of invasion status. Twenty-six percent of renal pelvis UTUC and 36% of ureter UTUC were invasive only on resection. Of 18 UTUCs reclassified from noninvasive high-grade papillary urothelial carcinoma to invasive high-grade papillary urothelial carcinoma, 39% had prior radical cystectomy (versus 8% invasive UTUC and 11% noninvasive UTUC with concordant biopsies). Most high-grade UTUC (88%) and some low-grade UTUC (58%) resections had abnormal cytology results. Biopsy-resection pairs with concordant invasion status and pairs with discordant invasion status showed similar rates of recurrence (38% versus 38%) and metastasis (25% versus 27%). Fourteen percent of UUT biopsies lacked diagnostic neoplastic material. Grade concordance between biopsy and resection was high (89%), but 30% of cases showed invasion only on resection. Subepithelial tissue was less commonly present in ureter biopsies, particularly from the midureter or proximal ureter. UTUC in patients with prior cystectomy were more likely to show invasion on resection but not biopsy.

Identifiants

pubmed: 30537495
pii: S0046-8177(18)30475-1
doi: 10.1016/j.humpath.2018.11.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-84

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Caroline T Simon (CT)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

Stephanie L Skala (SL)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

Alon Z Weizer (AZ)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Sapan N Ambani (SN)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Arul M Chinnaiyan (AM)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, 1500, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Ganesh Palapattu (G)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Khaled Hafez (K)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Martin J Magers (MJ)

Department of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Samuel D Kaffenberger (SD)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Daniel E Spratt (DE)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.

Jeffrey S Montgomery (JS)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Todd M Morgan (TM)

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Aaron M Udager (AM)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Madelyn Lew (M)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

Rohit Mehra (R)

Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: mrohit@med.umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH